Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP567743.RAZioXVJ4tMOlwwNpVWQhMHHBIUERefUWd0-YRA5wq8Tc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP567743.RAZioXVJ4tMOlwwNpVWQhMHHBIUERefUWd0-YRA5wq8Tc130_assertion type Assertion NP567743.RAZioXVJ4tMOlwwNpVWQhMHHBIUERefUWd0-YRA5wq8Tc130_head.
- NP567743.RAZioXVJ4tMOlwwNpVWQhMHHBIUERefUWd0-YRA5wq8Tc130_assertion wasGeneratedBy ECO_0000203 NP567743.RAZioXVJ4tMOlwwNpVWQhMHHBIUERefUWd0-YRA5wq8Tc130_provenance.
- NP567743.RAZioXVJ4tMOlwwNpVWQhMHHBIUERefUWd0-YRA5wq8Tc130_assertion wasDerivedFrom befree-2016 NP567743.RAZioXVJ4tMOlwwNpVWQhMHHBIUERefUWd0-YRA5wq8Tc130_provenance.
- NP567743.RAZioXVJ4tMOlwwNpVWQhMHHBIUERefUWd0-YRA5wq8Tc130_assertion SIO_000772 16953233 NP567743.RAZioXVJ4tMOlwwNpVWQhMHHBIUERefUWd0-YRA5wq8Tc130_provenance.
- NP567743.RAZioXVJ4tMOlwwNpVWQhMHHBIUERefUWd0-YRA5wq8Tc130_assertion evidence source_evidence_literature NP567743.RAZioXVJ4tMOlwwNpVWQhMHHBIUERefUWd0-YRA5wq8Tc130_provenance.
- NP567743.RAZioXVJ4tMOlwwNpVWQhMHHBIUERefUWd0-YRA5wq8Tc130_assertion description "[The frequency of KRAS and/or BRAF mutations was higher in LN metastases than in primary carcinomas (P=0.0002).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP567743.RAZioXVJ4tMOlwwNpVWQhMHHBIUERefUWd0-YRA5wq8Tc130_provenance.